AbbVie posts 4Q loss on Shire deal breakup fee but adjusted results top expectations on Humira
January 30, 2015 at 08:31 AM EST
Drugmaker Abbvie posted better-than-expected adjusted results for the fourth quarter on Friday due to double-digit growth of its blockbuster anti-inflammatory drug Humira.
